600873 梅花生物
交易中 11-27 09:37:33
资讯
新帖
简况
11月26日梅花生物现203.01万元大宗交易
证券之星 · 11-26 17:21
11月26日梅花生物现203.01万元大宗交易
“合成生物龙头”5亿元购入海外资产,梅花生物补强业务短板但新添业绩“包袱”
钛媒体APP · 11-26 10:02
“合成生物龙头”5亿元购入海外资产,梅花生物补强业务短板但新添业绩“包袱”
海通国际:给予梅花生物增持评级,目标价位11.56元
证券之星 · 11-25 17:27
海通国际:给予梅花生物增持评级,目标价位11.56元
梅花生物11月25日主力资金流出3345万元 连续3日减仓
市场透视 · 11-25 15:20
梅花生物11月25日主力资金流出3345万元 连续3日减仓
梅花生物:跨境收购资产丰富产品矩阵 加快海外布局步伐;氨基酸盈利显著修复 24Q4业绩可期
申万宏源研究 · 11-25 00:00
梅花生物:跨境收购资产丰富产品矩阵 加快海外布局步伐;氨基酸盈利显著修复 24Q4业绩可期
梅花生物拟出资5亿买协和发酵旗下业务及资产 交易涉及诸多风险
新京报 · 11-22
梅花生物拟出资5亿买协和发酵旗下业务及资产 交易涉及诸多风险
5亿元 梅花生物拟跨境收购食品氨基酸等业务
每日经济新闻 · 11-22
5亿元 梅花生物拟跨境收购食品氨基酸等业务
梅花生物:拟以105亿日元跨境收购业务与资产
每日经济新闻 · 11-22
梅花生物:拟以105亿日元跨境收购业务与资产
梅花生物:拟5亿元收购协和发酵业务及资产
券中社 · 11-22
梅花生物:拟5亿元收购协和发酵业务及资产
梅花生物(600873.SH)子公司拟5亿元收购协和发酵旗下食品氨基酸、医药氨基酸及HMO业务
智通财经 · 11-22
梅花生物(600873.SH)子公司拟5亿元收购协和发酵旗下食品氨基酸、医药氨基酸及HMO业务
梅花生物:拟5亿元收购协和发酵旗下食品氨基酸、医药氨基酸及HMO业务
证券之星 · 11-22
梅花生物:拟5亿元收购协和发酵旗下食品氨基酸、医药氨基酸及HMO业务
XD梅花生11月22日遭主力抛售5227万元 环比增加381.75%
市场透视 · 11-22
XD梅花生11月22日遭主力抛售5227万元 环比增加381.75%
梅花生物(600873.SH)2024年半年度权益分派:每股派0.17596元 11月21日股权登记
智通财经 · 11-17
梅花生物(600873.SH)2024年半年度权益分派:每股派0.17596元 11月21日股权登记
梅花生物11月14日主力资金流出1749万元 连续3日减仓
市场透视 · 11-14
梅花生物11月14日主力资金流出1749万元 连续3日减仓
梅花生物:从农产品视角看公司的业绩上行周期
中信建投证券 · 11-13
梅花生物:从农产品视角看公司的业绩上行周期
研报掘金丨山西证券:首予梅花生物“增持-A”评级,关注苏、赖价格上涨
格隆汇 · 11-12
研报掘金丨山西证券:首予梅花生物“增持-A”评级,关注苏、赖价格上涨
山西证券:给予梅花生物增持评级
证券之星 · 11-11
山西证券:给予梅花生物增持评级
梅花生物11月08日遭主力抛售3245万元 环比增加1304.76%
市场透视 · 11-08
梅花生物11月08日遭主力抛售3245万元 环比增加1304.76%
梅花生物11月07日主力资金流出231万元 连续5日减仓
市场透视 · 11-07
梅花生物11月07日主力资金流出231万元 连续5日减仓
梅花生物11月05日遭主力抛售3119万元 环比增加1642.46%
市场透视 · 11-05
梅花生物11月05日遭主力抛售3119万元 环比增加1642.46%
加载更多
公司概况
公司名称:
梅花生物科技集团股份有限公司
所属行业:
食品制造业
上市日期:
1995-02-17
主营业务:
梅花生物科技集团股份有限公司主要从事氨基酸系列产品研发、生产及销售的公司。公司的主要产品有动物营养氨基酸类产品:赖氨酸、苏氨酸、色氨酸、饲料级缬氨酸、味精渣,淀粉附产品饲料纤维、玉米胚芽、菌体蛋白等;食品味觉性状优化产品:谷氨酸、谷氨酸钠、呈味核苷酸二钠、肌苷酸二钠、食品级黄原胶、海藻糖、纳他霉素等;人类医用氨基酸类:谷氨酰胺、脯氨酸、亮氨酸、异亮氨酸、医药级缬氨酸、肌苷、鸟苷、腺苷、普鲁兰多糖等;其他产品:石油级黄原胶、药用胶囊、生物有机肥等。
发行价格:
3.50
{"stockData":{"symbol":"600873","market":"SH","secType":"STK","nameCN":"梅花生物","latestPrice":10.06,"timestamp":1732671453000,"preClose":10.1,"halted":0,"volume":1560400,"delay":0,"floatShares":2853000000,"shares":2853000000,"eps":1.0572,"marketStatus":"交易中","marketStatusCode":2,"change":-0.04,"latestTime":"11-27 09:37:33","open":10.09,"high":10.1,"low":10.01,"amount":15693000,"amplitude":0.0089,"askPrice":10.07,"askSize":131,"bidPrice":10.06,"bidSize":147,"shortable":0,"etf":0,"ttmEps":1.0572,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1732678200000},"adr":0,"adjPreClose":10.1,"symbolType":"stock","openAndCloseTimeList":[[1732671000000,1732678200000],[1732683600000,1732690800000]],"highLimit":11.11,"lowLimit":9.09,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":2852788750,"pbRate":1.96,"roa":"--","roe":"13.92%","epsLYR":1.06,"committee":0.150043,"marketValue":28699000000,"floatMarketCap":28699000000,"peRate":9.515702,"changeRate":-0.004,"turnoverRate":0.0005,"status":1},"requestUrl":"/m/hq/s/600873","defaultTab":"news","newsList":[{"id":"2486029748","title":"11月26日梅花生物现203.01万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2486029748","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486029748?lang=zh_cn&edition=full","pubTime":"2024-11-26 17:21","pubTimestamp":1732612880,"startTime":"0","endTime":"0","summary":"证券之星消息,11月26日梅花生物发生大宗交易,交易数据如下:大宗交易成交价格10.1元,成交20.1万股,成交金额203.01万元,买方营业部为华泰证券股份有限公司总部,卖方营业部为中信证券股份有限公司上海分公司。近三个月该股共发生1笔大宗交易,合计成交2010.0手。截至2024年11月26日收盘,梅花生物报收于10.1元,下跌1.17%,换手率0.8%,成交量22.8万手,成交额2.31亿元。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112600030468.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0226","BK0070","600873","BK0028","BK0012","BK0033"],"gpt_icon":0},{"id":"2486209091","title":"“合成生物龙头”5亿元购入海外资产,梅花生物补强业务短板但新添业绩“包袱”","url":"https://stock-news.laohu8.com/highlight/detail?id=2486209091","media":"钛媒体APP","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486209091?lang=zh_cn&edition=full","pubTime":"2024-11-26 10:02","pubTimestamp":1732586549,"startTime":"0","endTime":"0","summary":"麒麟控股公告称,预计本次转让需要进行包括药品生产许可等一系列的移交手续,将在2025年第四季度完成。换句话说,尽管麒麟控股折价出售了协和发酵的业务和资产给梅花生物,并承诺在交割前清偿借款,但这部分业务本身的盈利能力仍然不容乐观。目前,医药氨基酸业务板块在三大业务中处于弱势,而本次收购标的的长板正是医药氨基酸品种。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126101209abdf471b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126101209abdf471b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","BK0188","BK0033","BK0070","BK0012","600873","BK0226"],"gpt_icon":0},{"id":"2486703619","title":"海通国际:给予梅花生物增持评级,目标价位11.56元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486703619","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486703619?lang=zh_cn&edition=full","pubTime":"2024-11-25 17:27","pubTimestamp":1732526877,"startTime":"0","endTime":"0","summary":"海通国际证券集团有限公司孙小涵近期对梅花生物进行研究并发布了研究报告《公司拟收购协和发酵氨基酸和HMO业务,加快海外布局步伐》,本报告对梅花生物给出增持评级,认为其目标价位为11.56元,当前股价为10.22元,预期上涨幅度为13.11%。 协和发酵拟计提一次性转让损失及费用约290亿元。最新盈利预测明细如下:该股最近90天内共有11家机构给出评级,买入评级7家,增持评级4家;过去90天内机构目标均价为13.91。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112500024483.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600873"],"gpt_icon":0},{"id":"2486771529","title":"梅花生物11月25日主力资金流出3345万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2486771529","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486771529?lang=zh_cn&edition=full","pubTime":"2024-11-25 15:20","pubTimestamp":1732519234,"startTime":"0","endTime":"0","summary":"11月25日, 梅花生物股价跌3.13%,报收10.22元,成交金额5.24亿元,换手率1.77%,振幅5.69%,量比1.14。梅花生物今日主力资金净流出3345万元,连续3日净流出,上一交易日主力净流出5227万元,今日环比减少36.01%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为50.00%,平均跌幅为0.86%。该股近5个交易日上涨2.66%,主力资金累计净流出9694万元;近20日主力资金累计净流出2.68亿元,其中净流出天数为16日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125153943abdd27fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125153943abdd27fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0012","BK0188","BK0028","BK0070","BK0226","BK0033","600873"],"gpt_icon":0},{"id":"2486079667","title":"梅花生物:跨境收购资产丰富产品矩阵 加快海外布局步伐;氨基酸盈利显著修复 24Q4业绩可期","url":"https://stock-news.laohu8.com/highlight/detail?id=2486079667","media":"申万宏源研究","labels":["Company Corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486079667?lang=zh_cn&edition=full","pubTime":"2024-11-25 00:00","pubTimestamp":1732464000,"startTime":"0","endTime":"0","summary":"跨境收购扩充产品矩阵,依托海外生产基地,加快实施海外战略布局。交易完成后,不仅丰富了公司产品管线,同时还将新增海外生产和经营实体,加快公司海外布局步伐。24Q4 公司味精产品价格持续承压,赖氨酸、苏氨酸价格上调,价差同环比扩大,单季度业绩有望创年内新高。24Q4 虽然公司味精等产品盈利持续承压,但是在主要氨基酸产品盈利的显著改善下,我们预计业绩有望实现大幅改善,创年内新高。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125193128a25434b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125193128a25434b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Company Corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0188","BK0226","BK0070","600873","BK0028","BK0012","BK0033"],"gpt_icon":0},{"id":"2485726447","title":"梅花生物拟出资5亿买协和发酵旗下业务及资产 交易涉及诸多风险","url":"https://stock-news.laohu8.com/highlight/detail?id=2485726447","media":"新京报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485726447?lang=zh_cn&edition=full","pubTime":"2024-11-22 22:40","pubTimestamp":1732286400,"startTime":"0","endTime":"0","summary":"11月22日,梅花生物发布关于跨境收购业务与资产并签署《股份及资产购买协议》的公告。公告显示,梅花生物拟以105亿日元收购Kirin Holdings Company,Limited的全资子公司Kyowa Hakko Bio Co.,Ltd.旗下的食品氨基酸、医药氨基酸、母乳低聚糖业务及资产。因此,本次交易的交易过程及交割后可能存在诸多风险,包括交割风险、收购整合风险、不可抗力风险。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122224803a24e2850&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122224803a24e2850&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0188","BK0012","BK0028","BK0070","BK0226","BK0033","600873"],"gpt_icon":0},{"id":"2485690482","title":"5亿元 梅花生物拟跨境收购食品氨基酸等业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2485690482","media":"每日经济新闻","labels":["Company Corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485690482?lang=zh_cn&edition=full","pubTime":"2024-11-22 22:09","pubTimestamp":1732284540,"startTime":"0","endTime":"0","summary":"11月22日晚,梅花生物公告称,公司拟以105亿日元收购Kyowa Hakko Bio Co.,Ltd.旗下的食品氨基酸、医药氨基酸、母乳低聚糖业务及资产。梅花生物明确表示,交易完成后,将在全球范围内对现有的供产销全业务链条实施整合。而梅花生物的境外收入占比正逐步提高。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122221352a24e18cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122221352a24e18cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Company Corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0033","BK0012","BK0028","BK0188","BK0226","BK0070","600873"],"gpt_icon":0},{"id":"2485254980","title":"梅花生物:拟以105亿日元跨境收购业务与资产","url":"https://stock-news.laohu8.com/highlight/detail?id=2485254980","media":"每日经济新闻","labels":["Company Corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485254980?lang=zh_cn&edition=full","pubTime":"2024-11-22 20:06","pubTimestamp":1732277171,"startTime":"0","endTime":"0","summary":"每经AI快讯,梅花生物 11月22日晚间发布公告称,公司拟以105亿日元收购Kirin Holdings Company, Limited的全资子公司Kyowa Hakko Bio Co., Ltd.旗下的食品氨基酸、医药氨基酸、母乳低聚糖业务及资产。交割完成后,公司将利用获得的三十项与氨基酸及HMO业务相关的专利,进一步优化生产菌种及工艺技术,增强公司在氨基酸领域的全球知识产权布局。截至发稿,梅花生物市值为301亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122200706a24ddfa4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122200706a24ddfa4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Company Corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0226","600873","BK0188","BK0028","BK0033","BK0070","BK0012"],"gpt_icon":0},{"id":"2485256730","title":"梅花生物:拟5亿元收购协和发酵业务及资产","url":"https://stock-news.laohu8.com/highlight/detail?id=2485256730","media":"券中社","labels":["Company Corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485256730?lang=zh_cn&edition=full","pubTime":"2024-11-22 19:40","pubTimestamp":1732275653,"startTime":"0","endTime":"0","summary":"券中社11月22日讯,梅花生物公告,公司拟以105亿日元(约合人民币5亿元左右)收购麒麟控股的全资子公司协和发酵旗下食品氨基酸、医药氨基酸及母乳低聚糖业务及资产。此次交易不构成关联交易或重大资产重组,尚需履行相关审批程序。交易完成后,公司将获得多种氨基酸新品类、生产技术和相关专利,并加强在全球氨基酸领域的知识产权布局。本次收购符合公司发展战略,有助于拓展产品线并增加海外生产经营实体。交易过程及交割后可能存在交割风险、整合风险及不可抗力风险。校对:王锦程","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122194105a24dd331&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122194105a24dd331&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Company Corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0188","BK0033","BK0226","600873","BK0028","BK0012","BK0070"],"gpt_icon":0},{"id":"2485256916","title":"梅花生物(600873.SH)子公司拟5亿元收购协和发酵旗下食品氨基酸、医药氨基酸及HMO业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2485256916","media":"智通财经","labels":["Company Corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485256916?lang=zh_cn&edition=full","pubTime":"2024-11-22 19:34","pubTimestamp":1732275249,"startTime":"0","endTime":"0","summary":"智通财经APP讯,梅花生物 发布公告,为满足业务发展需要,公司全资子公司 PLUM BIOTECHNOLOGY GROUP PTE. LTD.拟与麒麟控股全资子公司协和发酵签署《股份及资产购买协议》,新加坡公司或新加坡公司下新设的特殊目的实体拟以105亿日元现金收购协和发酵旗下食品氨基酸、医药氨基酸及HMO业务,本次交易以最终签署的相关协议为准,资金来源为自有资金或自筹资金。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1214855.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Company Corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0226","BK0070","BK0012","BK1161","159938","BK0033","600873","BK0028","BK1515","BK0188","09939","BK1574"],"gpt_icon":0},{"id":"2485137255","title":"梅花生物:拟5亿元收购协和发酵旗下食品氨基酸、医药氨基酸及HMO业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2485137255","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485137255?lang=zh_cn&edition=full","pubTime":"2024-11-22 19:10","pubTimestamp":1732273855,"startTime":"0","endTime":"0","summary":"梅花生物公告称,公司全资子公司新加坡公司拟以105亿日元(约合人民币5亿元)现金,收购麒麟控股全资子公司协和发酵旗下的食品氨基酸、医药氨基酸及HMO业务。本次交易将为公司带来技术能力、业务结构、产品结构及产业布局等多方面的提升和扩展。然而,由于交易架构复杂,涉及全球多地的法律、财务、税务和合规运营等事项,存在交割风险、收购整合风险及不可抗力风险。交易实施尚需履行相关审批及其他程序。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112200036084.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09939","BK0070","600873","159938","BK0226","BK0012","BK1574","BK0033","BK0028","BK1161","BK0188","BK1515"],"gpt_icon":0},{"id":"2485287550","title":"XD梅花生11月22日遭主力抛售5227万元 环比增加381.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485287550","media":"市场透视","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485287550?lang=zh_cn&edition=full","pubTime":"2024-11-22 15:19","pubTimestamp":1732259969,"startTime":"0","endTime":"0","summary":"11月22日, XD梅花生股价跌0.19%,报收10.55元,成交金额6.67亿元,换手率2.20%,振幅3.97%,量比1.60。XD梅花生今日主力资金净流出5227万元,上一交易日主力净流出1085万元,今日环比增加381.75%。该股近5个交易日上涨6.40%,主力资金累计净流出5702万元;近20日主力资金累计净流出2.18亿元,其中净流出天数为15日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122153054a24d48f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122153054a24d48f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0012","600873","BK0070","BK0188","BK0033","BK0028","BK0226"],"gpt_icon":0},{"id":"2484022895","title":"梅花生物(600873.SH)2024年半年度权益分派:每股派0.17596元 11月21日股权登记","url":"https://stock-news.laohu8.com/highlight/detail?id=2484022895","media":"智通财经","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484022895?lang=zh_cn&edition=full","pubTime":"2024-11-17 15:45","pubTimestamp":1731829543,"startTime":"0","endTime":"0","summary":"智通财经APP讯,梅花生物(600873.SH)发布2024年半年度权益分派公告,以实施权益分派股权登记日登记的总股本为基数,向全体股东每股分派现金股利0.17596元(含税)。股权登记日为2024/11/21,除权(息)日为2024/11/22。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1211938.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0070","BK0012","BK0226","BK0188","BK0028","600873","BK0033"],"gpt_icon":0},{"id":"2483846361","title":"梅花生物11月14日主力资金流出1749万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2483846361","media":"市场透视","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483846361?lang=zh_cn&edition=full","pubTime":"2024-11-14 15:20","pubTimestamp":1731568808,"startTime":"0","endTime":"0","summary":"11月14日, 梅花生物股价跌1.88%,报收9.93元,成交金额2.47亿元,换手率0.86%,振幅2.67%,量比0.60。梅花生物今日主力资金净流出1749万元,连续3日净流出,上一交易日主力净流出1025万元,今日环比增加70.63%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为52.38%,平均跌幅为0.86%。该股近5个交易日上涨0.30%,主力资金累计净流出5969万元;近20日主力资金累计净流出1.37亿元,其中净流出天数为13日。净流出前三个股分别为万华化学、多氟多、正丹股份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114153706abc01944&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114153706abc01944&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0188","BK0226","BK0070","600873","BK0028","BK0012","BK0033"],"gpt_icon":0},{"id":"2483800152","title":"梅花生物:从农产品视角看公司的业绩上行周期","url":"https://stock-news.laohu8.com/highlight/detail?id=2483800152","media":"中信建投证券","labels":["Business Data"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483800152?lang=zh_cn&edition=full","pubTime":"2024-11-13 00:00","pubTimestamp":1731427200,"startTime":"0","endTime":"0","summary":"摘要公司业绩波动与玉米、豆粕两大农产品密切相关,本文重点从农产品角度看公司业绩趋势。市场在关注公司所在的生物制造行业时,大多按照一般周期品规律以供需视角入手,但对于农产品价格因素的影响则缺乏探究。本文主要内容即为厘清农产品价格周期对公司业绩的影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202411132016269f5969c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202411132016269f5969c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Business Data","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0016","600873","BK0028","BK0070","BK0188","BK0226","BK0033","000061","BK0210","BK0027","BK0012"],"gpt_icon":0},{"id":"2482720486","title":"研报掘金丨山西证券:首予梅花生物“增持-A”评级,关注苏、赖价格上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2482720486","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482720486?lang=zh_cn&edition=full","pubTime":"2024-11-12 16:56","pubTimestamp":1731401811,"startTime":"0","endTime":"0","summary":"格隆汇11月12日|山西证券研报指出,味精、黄原胶等主要产品价格下降影响梅花生物(600873.SH)业绩。三季度公司苏氨酸、饲料级缬氨酸、赖氨酸等产品销量增长,但由于味精、黄原胶及淀粉副产品市场销售价格下降,导致营收及毛利率承压。公司长期坚持高分红、高回购回报股东。公司上市以来累计分红108.47亿元,上市以来平均分红率为52.77%。10月以来公司披露回购计划,回购金额不低于人民币3亿元,不超过人民币5亿元。长期看,公司在味精、赖氨酸、苏氨酸三大产品具备稳固的领先地位,持续分红回购汇报股东,短期看,赖氨酸、苏氨酸等产品价格抬升对业绩形成支撑,首次覆盖给予“增持-A”评级。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112165655abb9669c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112165655abb9669c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["002500","600873"],"gpt_icon":0},{"id":"2482119203","title":"山西证券:给予梅花生物增持评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2482119203","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482119203?lang=zh_cn&edition=full","pubTime":"2024-11-11 17:45","pubTimestamp":1731318316,"startTime":"0","endTime":"0","summary":"山西证券股份有限公司冀泳洁,王锐近期对梅花生物进行研究并发布了研究报告《味精价格下行拖累三季度业绩,关注苏、赖价格上涨》,本报告对梅花生物给出增持评级,当前股价为10.13元。 事件点评 三季度氨基酸景气上行,苏氨酸及98.5%赖氨酸价格抬升。长期看,公司在味精、赖氨酸、苏氨酸三大产品具备稳固的领先地位,持续分红回购汇报股东,短期看,赖氨酸、苏氨酸等产品价格抬升对业绩形成支撑,首次覆盖给予“增持-A”评级。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111100022858.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600873","002500"],"gpt_icon":0},{"id":"2481146570","title":"梅花生物11月08日遭主力抛售3245万元 环比增加1304.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481146570","media":"市场透视","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481146570?lang=zh_cn&edition=full","pubTime":"2024-11-08 15:19","pubTimestamp":1731050368,"startTime":"0","endTime":"0","summary":"11月08日, 梅花生物股价跌0.40%,报收9.86元,成交金额4.08亿元,换手率1.45%,振幅1.82%,量比0.93。梅花生物今日主力资金净流出3245万元,连续6日净流出,上一交易日主力净流出231万元,今日环比增加1304.76%。近一年数据显示,该股主力连续6日净流出后,次日下跌概率为50.00%,平均跌幅为0.71%。该股近5个交易日上涨3.90%,主力资金累计净流出8229万元;近20日主力资金累计净流出1.06亿元,其中净流出天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108154018abacbda9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108154018abacbda9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0033","BK0028","BK0012","BK0226","BK0070","BK0188","600873"],"gpt_icon":0},{"id":"2481281719","title":"梅花生物11月07日主力资金流出231万元 连续5日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2481281719","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481281719?lang=zh_cn&edition=full","pubTime":"2024-11-07 15:18","pubTimestamp":1730963887,"startTime":"0","endTime":"0","summary":"11月07日, 梅花生物股价涨2.91%,报收9.90元,成交金额5.24亿元,换手率1.87%,振幅4.37%,量比1.36。梅花生物今日主力资金净流出231万元,连续5日净流出,上一交易日主力净流出1457万元,今日环比减少84.15%。近一年数据显示,该股主力连续5日净流出后,次日下跌概率为50.00%,平均跌幅为0.90%。该股近5个交易日上涨4.76%,主力资金累计净流出7369万元;近20日主力资金累计净流出7605万元,其中净流出天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107152631a21f8688&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107152631a21f8688&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0033","BK0012","BK0028","BK0188","BK0226","BK0070","600873"],"gpt_icon":0},{"id":"2481440215","title":"梅花生物11月05日遭主力抛售3119万元 环比增加1642.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481440215","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481440215?lang=zh_cn&edition=full","pubTime":"2024-11-05 15:17","pubTimestamp":1730791049,"startTime":"0","endTime":"0","summary":"11月05日,梅花生物股价收平报9.71元,成交金额4.21亿元,换手率1.53%,振幅1.96%,量比1.13。梅花生物今日主力资金净流出3119万元,连续3日净流出,上一交易日主力净流出179万元,今日环比增加1642.46%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为57.14%,平均跌幅为0.80%。该股近5个交易日上涨2.32%,主力资金累计净流出6689万元;近20日主力资金累计净流出7327万元,其中净流出天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105152049aba0fe87&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105152049aba0fe87&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0070","BK0012","BK0226","BK0188","BK0028","600873","BK0033"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"1995-02-17","address":"西藏自治区拉萨市堆龙德庆区金珠西路158号阳光新城11幢5号","stockEarnings":[{"period":"1week","weight":-0.0059},{"period":"1month","weight":0.0554},{"period":"3month","weight":0.0521},{"period":"6month","weight":-0.047},{"period":"1year","weight":0.1403},{"period":"ytd","weight":0.1176}],"companyName":"梅花生物科技集团股份有限公司","boardCode":"AI0014","perCapita":"40473股","boardName":"食品制造业","registeredCapital":"285278万元","compareEarnings":[{"period":"1week","weight":-0.0258},{"period":"1month","weight":-0.0121},{"period":"3month","weight":0.1488},{"period":"6month","weight":0.0544},{"period":"1year","weight":0.0752},{"period":"ytd","weight":0.0957}],"survey":" 梅花生物科技集团股份有限公司主要从事氨基酸系列产品研发、生产及销售的公司。公司的主要产品有动物营养氨基酸类产品:赖氨酸、苏氨酸、色氨酸、饲料级缬氨酸、味精渣,淀粉附产品饲料纤维、玉米胚芽、菌体蛋白等;食品味觉性状优化产品:谷氨酸、谷氨酸钠、呈味核苷酸二钠、肌苷酸二钠、食品级黄原胶、海藻糖、纳他霉素等;人类医用氨基酸类:谷氨酰胺、脯氨酸、亮氨酸、异亮氨酸、医药级缬氨酸、肌苷、鸟苷、腺苷、普鲁兰多糖等;其他产品:石油级黄原胶、药用胶囊、生物有机肥等。","serverTime":1732671460927,"listedPrice":3.5,"stockholders":"70485人(较上一季度增加0.25%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"梅花生物(600873)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供梅花生物(600873)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"梅花生物,600873,梅花生物股票,梅花生物股票老虎,梅花生物股票老虎国际,梅花生物行情,梅花生物股票行情,梅花生物股价,梅花生物股市,梅花生物股票价格,梅花生物股票交易,梅花生物股票购买,梅花生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"梅花生物(600873)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供梅花生物(600873)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}